drugset / Trial / NCT04043520
Bioenergetic Effects of Aging and Menopause (BEAM)
Phase 4
Unknown
57 enrolled
University of Colorado, Denver
National Institute on Aging (NIA) · collab
RandomizedParallel-groupTriple-blindBasic science
Summary
The menopause transition is associated with increased risk for weight gain and a shift toward storing fat in the belly region, which may increase risk for cardiovascular disease and diabetes. The study will determine whether the stress hormone cortisol contributes to this shift.
Timeline
- Start
- 2019-09-24
- Primary completion
- 2024-08-31
- Completion
- 2024-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Estradiol | Other / unclassified | 0.075 mg | Other |
| Subject | GnRH antagonist | Unknown | 80 mg | Subcutaneous |